Table 1. Demographics and baseline characteristics of the enrolled participants.
| Sociodemographic characteristics | Total | CCTA obstructive stenosis | SPECT—ischemia | ||||
|---|---|---|---|---|---|---|---|
| No | Yes | p | No | Yes | p | ||
| N = 956 | N = 818 | N = 138 | N = 818 | N = 138 | |||
| Age–Mean (SD) | 61.14 (14.20) | 59.97 (14.21) | 68.04 (12.05) | <0.001 | 61.02 (14.26) | 61.84 (13.87) | 0.53 |
| Sex–Female N (%) | 439 (46%) | 386 (47%) | 53 (38%) | 0.055 | 385 (47%) | 54 (39%) | 0.084 |
| Comorbidities | |||||||
| Hypertension–N (%) | 848 (89%) | 719 (88%) | 129 (93%) | 0.055 | 720 (88%) | 128 (93%) | 0.10 |
| Diabetes–N (%) | 778 (81%) | 659 (81%) | 119 (86%) | 0.11 | 657 (80%) | 121 (88%) | 0.040 |
| Dyslipidemia–N (%) | 806 (84%) | 674 (82%) | 132 (96%) | <0.001 | 680 (83%) | 126 (91%) | 0.015 |
| Heart failure–N (%) | 107 (11%) | 86 (11%) | 21 (15%) | 0.10 | 85 (10%) | 22 (16%) | 0.056 |
| Ever smoker–N (%) | 317 (33%) | 257 (31%) | 60 (43%) | 0.005 | 263 (32%) | 54 (39%) | 0.11 |
| Symptoms | |||||||
| Chest pain or shortness of breath–N (%) | 537 (56%) | 474 (58%) | 63 (46%) | 0.007 | 472 (58%) | 65 (47%) | 0.020 |
| Medication | |||||||
| Aspirin/Clopidogrel–N (%) | 768 (80%) | 645 (79%) | 123 (89%) | 0.005 | 647 (79%) | 121 (88%) | 0.019 |
| Statin–N (%) | 706 (74%) | 582 (71%) | 124 (90%) | <0.001 | 589 (72%) | 117 (85%) | 0.002 |
| ACE/ARB–N (%) | 625 (65%) | 525 (64%) | 100 (72%) | 0.059 | 527 (64%) | 98 (71%) | 0.13 |
| Beta blockers–N (%) | 770 (81%) | 654 (80%) | 116 (84%) | 0.26 | 645 (79%) | 125 (91%) | 0.001 |
| Calcium channel blockers–N (%) | 431 (45%) | 359 (44%) | 72 (52%) | 0.070 | 369 (45%) | 62 (45%) | 0.97 |